SCHEMBL29035720

SCHEMBL29035720

C#Cc1ccc(NCC)cc1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.43
NOX4 Q9NPH5 1/20 0.43
TDP1 Q9NUW8 1/20 0.39
CDK1 P06493 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 2/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29035734 0.83 GAA (0.50) TDP1CDK1SMN1; SMN2LMNAMEN1
SCHEMBL29035714 0.83 KDM4E (0.41) EGFRNOX4TDP1CDK1SMN1; SMN2
SCHEMBL2114067 0.78 POLB (0.51) CDK1SMN1; SMN2LMNAKDM4EGAA
SCHEMBL23717441 0.77 ALDH1A1 (0.59) EGFRNOX4TDP1CDK1SMN1; SMN2
SCHEMBL21900515 0.77 KMT2A (0.58) EGFRNOX4TDP1SMN1; SMN2LMNA
SCHEMBL1914436 0.76 PTPN11 (0.40) LMNAMEN1KMT2AKDM4EGAA
SCHEMBL13277325 0.75 ABL1 (0.54) SMN1; SMN2LMNAMEN1KMT2AKDM4E
SCHEMBL17883969 0.75 IDH1 (0.38) MEN1KMT2AKDM4EGAAALDH1A1
SCHEMBL19583419 0.75 NR4A2 (0.48) SMN1; SMN2GAAHPGDALDH1A1L3MBTL1
SCHEMBL15763208 0.75 SMN1; SMN2 (0.64) EGFRNOX4TDP1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110678450-B Isoxazole derivatives as nuclear receptor agonists and uses thereof 日东制药株式会社 2023-06-20 CN disclosed